Pfizer Inventory Turnover Ratio 2006-2020 | PFE

Current and historical inventory turnover ratio for Pfizer (PFE) from 2006 to 2020. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Pfizer inventory turnover ratio for the three months ending March 31, 2020 was 0.28.
Pfizer Inventory Turnover Ratio Historical Data
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $200.030B $51.750B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $386.574B 16.52
Roche Holding AG (RHHBY) Switzerland $296.540B 0.00
Merck (MRK) United States $205.840B 14.91
Novartis AG (NVS) Switzerland $195.078B 15.23
Novo Nordisk (NVO) Denmark $151.508B 25.23
Eli Lilly (LLY) United States $144.147B 23.33
AstraZeneca (AZN) United Kingdom $141.375B 29.12
Bristol-Myers Squibb (BMY) United States $137.775B 11.51
AbbVie (ABBV) United States $137.396B 10.09
Sanofi (SNY) $125.082B 14.48
GlaxoSmithKline (GSK) United Kingdom $104.480B 12.47
Bayer (BAYRY) Germany $66.771B 9.52
H Lundbeck (HLUYY) Denmark $8.078B 14.04
Innoviva (INVA) United States $1.403B 8.10